PL392774A1 - Kompetytywna metoda otrzymywania preparatów bakteriofagowych - Google Patents

Kompetytywna metoda otrzymywania preparatów bakteriofagowych

Info

Publication number
PL392774A1
PL392774A1 PL392774A PL39277410A PL392774A1 PL 392774 A1 PL392774 A1 PL 392774A1 PL 392774 A PL392774 A PL 392774A PL 39277410 A PL39277410 A PL 39277410A PL 392774 A1 PL392774 A1 PL 392774A1
Authority
PL
Poland
Prior art keywords
bacteriophage
phage
capsid
proposed method
facilitates
Prior art date
Application number
PL392774A
Other languages
English (en)
Other versions
PL218313B1 (pl
Inventor
Krystyna Dąbrowska
Anna Oślizło
Paulina Budynek
Agnieszka Piotrowicz
Andrzej Górski
Grzegorz Figura
Barbara Owczarek
Agnieszka Kopciuch
Original Assignee
Instytut Immunologii i Terapii Doświadczalnej PAN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Immunologii i Terapii Doświadczalnej PAN filed Critical Instytut Immunologii i Terapii Doświadczalnej PAN
Priority to PL392774A priority Critical patent/PL218313B1/pl
Priority to US13/881,795 priority patent/US10160956B2/en
Priority to EP11802172.4A priority patent/EP2632940B1/en
Priority to RU2013123514/10A priority patent/RU2590609C2/ru
Priority to PCT/PL2011/050044 priority patent/WO2012057643A1/en
Publication of PL392774A1 publication Critical patent/PL392774A1/pl
Publication of PL218313B1 publication Critical patent/PL218313B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/00051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae
    • C12N2795/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae
    • C12N2795/10151—Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL392774A 2010-10-28 2010-10-28 Kompetytywna metoda otrzymywania preparatów bakteriofagowych PL218313B1 (pl)

Priority Applications (5)

Application Number Priority Date Filing Date Title
PL392774A PL218313B1 (pl) 2010-10-28 2010-10-28 Kompetytywna metoda otrzymywania preparatów bakteriofagowych
US13/881,795 US10160956B2 (en) 2010-10-28 2011-10-28 Method of producing bacteriophage preparations comprising purification using affinity chromatography
EP11802172.4A EP2632940B1 (en) 2010-10-28 2011-10-28 A method of producing bacteriophage preparations comprising purification using affinity chromatography
RU2013123514/10A RU2590609C2 (ru) 2010-10-28 2011-10-28 Способ очистки бактериофагов
PCT/PL2011/050044 WO2012057643A1 (en) 2010-10-28 2011-10-28 A method of producing bacteriophage preparations comprising purification using affinity chromatography

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL392774A PL218313B1 (pl) 2010-10-28 2010-10-28 Kompetytywna metoda otrzymywania preparatów bakteriofagowych

Publications (2)

Publication Number Publication Date
PL392774A1 true PL392774A1 (pl) 2012-05-07
PL218313B1 PL218313B1 (pl) 2014-11-28

Family

ID=45418744

Family Applications (1)

Application Number Title Priority Date Filing Date
PL392774A PL218313B1 (pl) 2010-10-28 2010-10-28 Kompetytywna metoda otrzymywania preparatów bakteriofagowych

Country Status (5)

Country Link
US (1) US10160956B2 (pl)
EP (1) EP2632940B1 (pl)
PL (1) PL218313B1 (pl)
RU (1) RU2590609C2 (pl)
WO (1) WO2012057643A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2610178C1 (ru) * 2015-10-15 2017-02-08 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" (ФБУН ГНЦ ВБ "Вектор") Способ очистки нитчатого бактериофага М13

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69012682T2 (de) 1989-06-12 1995-04-06 Merck & Co Inc Verfahren zur Entfernung von bakteriellen Endotoxinen aus gram-negativen Polysacchariden.
US5039610A (en) 1989-06-12 1991-08-13 Merck & Co., Inc. Process for removing bacterial endotoxin from gram-negative polysaccharides
JP3402476B2 (ja) 1992-08-24 2003-05-06 生化学工業株式会社 リポ多糖結合性タンパク質及びその製造法
US20030162223A1 (en) * 1999-10-22 2003-08-28 Lowery David E. Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
WO2002008371A2 (en) 2000-02-17 2002-01-31 The Procter & Gamble Company Cleaning composition
US6942802B2 (en) 2001-04-13 2005-09-13 Wyeth Holdings Corporation Removal of bacterial endotoxin in a protein solution by immobilized metal affinity chromatography
RU2260053C2 (ru) 2002-06-26 2005-09-10 Апарин Петр Геннадьевич Способ выделения биологически активной фракции (баф), содержащей s-липополисахариды (s-лпс) из грамотрицательных бактерий, баф для лечения и профилактики заболеваний, вызываемых грамотрицательными бактериями, производящими эндотоксичные s-лпс, фармацевтическая композиция, способы индукции протективного иммунитета и улучшения состояния пациента при состояниях, требующих повышения иммунного статуса
FR2848223B1 (fr) 2002-12-09 2005-02-25 Centre Nat Rech Scient Nouveau procede d'isolement des endotoxines.
DE102004004043B4 (de) * 2004-01-27 2013-04-18 Apanovis Biotechnologie Gmbh Reinigung von hochmolekularen Verbindungen mittels Affinitätsmembranchromatographie
WO2007064462A1 (en) * 2005-11-29 2007-06-07 The Trustees Of The University Of Pennsylvania Phage particle diagnostic reagents
AR059448A1 (es) * 2006-02-13 2008-04-09 Divergence Inc Polipeptidos quimericos vegetales de union para el reconocimiento molecular universal
US8754013B2 (en) * 2008-09-11 2014-06-17 University Of Miami Open-reading-frame (ORF) phage display
PL212286B1 (pl) 2010-06-20 2012-09-28 Inst Immunologii I Terapii Doswiadczalnej Pan Sposób otrzymywania bakteriofagów

Also Published As

Publication number Publication date
EP2632940A1 (en) 2013-09-04
RU2590609C2 (ru) 2016-07-10
EP2632940B1 (en) 2017-05-10
WO2012057643A1 (en) 2012-05-03
PL218313B1 (pl) 2014-11-28
US20130295647A1 (en) 2013-11-07
US10160956B2 (en) 2018-12-25
RU2013123514A (ru) 2014-12-10

Similar Documents

Publication Publication Date Title
SG177025A1 (en) Hepatitis b virus specific antibody and uses thereof
NZ702458A (en) Benzo [c] isoxazoloazepine bromodomain inhibitors and uses thereof
WO2010016067A3 (en) Affinity purification by cohesin-dockerin interaction
MY158992A (en) Forms of rifaximin and uses thereof
ZA201202720B (en) Isolation and purification of anti-il-13 antibodies using protein a affinity chromatography
PL2195418T3 (pl) Sposób i układ do oczyszczania na skalę przemysłową bakteriofagów z przeznaczeniem do terapii bakteriofagowej
MX2008016036A (es) Vacuna viral recombinante.
WO2015021423A3 (en) Purification of chimeric fviii molecules
IL244157A0 (en) Isolation and purification of antibodies using protein a affinity chromatography
MX374811B (es) Anticuerpos anti-tau y métodos de uso.
MX2009011500A (es) Anticuerpos anti-mdl-1.
JOP20110402B1 (ar) الأجسام المضادة ل cd38
EA201070271A1 (ru) Пептиды для получения вакцины
WO2013078170A8 (en) Purification of anti-c-met antibodies
TW201129377A (en) Binding proteins that bind to human FGFR1c, human β-Klotho and both human FGFR1c and human β-Klotho
GB201016733D0 (en) Compounds and their use
PL3205397T3 (pl) Sposób odwodorniania butenów lub mieszanin butanów i butenów z wytworzeniem 1,3-butadienu
PL2117568T3 (pl) Oczyszczony bakteriofag, jego otrzymywanie i zastosowanie
NZ604412A (en) Vaccine and methods to reduce campylobacter infection
MX2016000393A (es) Modificaciones de proteinas quimioenzimaticas de lisina utilizando transglutaminasa microbiana.
MX2014013394A (es) Sal de clorhidrato de un peptido y su uso en combinacion con otros peptidos para inmunoterapia.
MX2011008179A (es) Peptidos para vacuna.
MX2010005701A (es) Metodo para producir cepa viral vacunal de un virus de la familia reoviridae.
WO2012078671A3 (en) Tricalcium phosphate binding peptides and uses thereof
PL392774A1 (pl) Kompetytywna metoda otrzymywania preparatów bakteriofagowych